Statement Of Cash Flows [Abstract]

Biofrontera AG - Filing #6520750

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
1,905 EUR
3,895 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
912,000 EUR
981,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
0 EUR
7,090 EUR
Repayments of borrowings, classified as financing activities
0 EUR
2,031 EUR
Payments of lease liabilities, classified as financing activities
467,000 EUR
453,000 EUR
Interest paid, classified as financing activities
12,000 EUR
198,000 EUR
Cash flows from (used in) financing activities
479,000 EUR
4,344 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
3,296 EUR
532,000 EUR
Cash and cash equivalents
3,080 EUR
6,376 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.